• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FT4 III ASSAY; RADIOIMMUNOASSAY, FREE THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FT4 III ASSAY; RADIOIMMUNOASSAY, FREE THYROXINE Back to Search Results
Model Number FT4 G3
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/17/2019
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).(b)(4).
 
Event Description
The initial reporter stated they received discrepant results for four patient samples tested with thyroid assays on the cobas 8000 e 801 module and the following analyzers used for investigation: a second e 801 analyzer, a cobas 8000 e 602 module, and a cobas e 411 immunoassay analyzer.Affected tests include elecsys ft3 iii, the elecsys ft4 iii assay, and the elecsys tsh assay.It was asked, but it is not known if any incorrect results were reported outside of the laboratory.This medwatch will apply to the ft4 assay.Please refer to the medwatch with patient identifier (b)(4) for information related to the ft3 assay and refer to the medwatch with patient identifier (b)(4) for information related to the tsh assay.Refer to the attachment for all patient data.Values highlighted in yellow are discrepant.The samples were initially tested on the reporter's e 801 analyzer on (b)(6) 2019.The sample was repeated on a centaur analyzer.The sample was also provided for investigation where it was tested on the e 602 analyzer and e411 analyzer used for investigation on (b)(6) 2019.During investigations, the sample was tested on the second e 801 analyzer on (b)(6) 2019.The e 801 analyzer used by the reporter is serial number (b)(4).The e 602 analyzer used for investigation is serial number (b)(4).Ft4 reagent lot number 391521, with an expiration date of 29-feb-2020 was used on this analyzer.The e411 analyzer used for investigation is serial number (b)(4).Ft4 reagent lot number 391521, with an expiration date of 29-feb-2020 was used on this analyzer.The e 801 analyzer used for investigation is serial number (b)(4).Ft4 reagent lot number 380330, with an expiration date of 31-dec-2019 was used on this analyzer.
 
Manufacturer Narrative
Upon further investigation of sample ids 191004-758, 191005-1412, and 191008-610, the values generated at the customer site could be reproduced.It was determined these samples contained an interfering factor to the streptavidin component of the ft3 and ft4 assays.This limitation is covered in product labeling.Product labeling states: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FT4 III ASSAY
Type of Device
RADIOIMMUNOASSAY, FREE THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key9280013
MDR Text Key219596460
Report Number1823260-2019-03973
Device Sequence Number1
Product Code CEC
Combination Product (y/n)N
PMA/PMN Number
K131244
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 02/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFT4 G3
Device Catalogue Number07976887190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 10/17/2019
Initial Date FDA Received11/05/2019
Supplement Dates Manufacturer Received10/17/2019
Supplement Dates FDA Received02/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-